Blogs

Tauzin on Roche/Genentech Leaving PhRMA: They Feel They Are Different

Notes from BIO 2009: Irish Pharma--Can Innovation and Quality Trump Cost and Infrastructure Considerations?

FDA's Most Wanted (or, the Rogues Gallery of Biotech)

Gephardt, AZ’s Brennan on Innovation: What Is Our Moon Shot?

Pfizer Reveals Details of Wyeth-Infused Corporate Structure

Can Academia Save Pharma? U Mich to Take Over Pfizer Site

A Biotech Bailout, in Some Form, Makes Sense

Getting the Big Picture: Notes From ISPE's 2008 Annual Meeting